Harold R Collard, MD, MS
Vice Chancellor for Research
Vice Chancellor Research
Chancellor/EVC/FAS

As vice chancellor for Research, Collard oversees and stewards UCSF's research mission. Deeply committed to advancing UCSF’s research mission, Collard previously served as associate vice chancellor of Clinical Research and director of UCSF’s Clinical and Translational Science Institute. In this role, he helped to position the University as a leader in the NIH’s national consortium of clinical research institutions and developed programs to support the needs of its clinical trialists and biospecimen-based researchers. During this time, Collard also helped lead the UCSF research community through the early phases of the SARS CoV-2 pandemic, advocating strongly for their needs.

As professor of Medicine and Health Policy, Collard has written seminal articles on the epidemiology, natural history, and management of interstitial lung disease, and is an internationally recognized clinical researcher. Collard has trained dozens of clinical and translational research fellows, a number of whom are now leading academic research programs in interstitial lung disease around the world.

• Interstitial Lung Disease in Veterans: Leveraging Big Data to Bridge Evidence and Practice Gaps.
  Annals of the American Thoracic Society 2023 Kaul B, Petersen LA, Rosas IO, Lee JS, Martinez FJ, Bandi VD, Helmer DA, Wolters PJ, Collard HR, Whooley MA
• Extracting patient-level data from the electronic health record: Expanding opportunities for health system research.
  PloS one 2023 Farrand E, Collard HR, Guarnieri M, Minowada G, Block L, Lee M, Iribarren C
• Three wishes for improving clinical drug development in pulmonary fibrosis.
  The European respiratory journal 2023 Collard HR
• Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis.
  Chest 2023 Kaul B, Lee JS, Petersen LA, McCulloch C, Rosas IO, Bandi VD, Zhang N, DeDent AM, Collard HR, Whooley MA
• Differences in Patient Outcomes across the Pulmonary Fibrosis Foundation Care Center Network.
  American journal of respiratory and critical care medicine 2023 Boente RD, White EN, Baxter CM, Shore JE, Collard HR, Lee JS, PFF Best Practices Committee
• Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire.
  Respirology (Carlton, Vic.) 2022 Barnes H, Chambers D, Grainge C, Corte TJ, Bastiampillai S, Frenkel S, Westall G, Collard H, Glaspole I
• Agent Orange Exposure and Risk of Idiopathic Pulmonary Fibrosis among U.S. Veterans.
  American journal of respiratory and critical care medicine 2022 Kaul B, Lee JS, Glidden DV, Blanc PD, Zhang N, Collard HR, Whooley MA
• A Call to Improve Health by Achieving the Learning Health Care System.
  Academic medicine : journal of the Association of American Medical Colleges 2022 Collard HR, Grumbach K
• Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective.
  American journal of respiratory and critical care medicine 2022 Cottin V, Tomassetti S, Valenzuela C, Walsh SLF, Antoniou KM, Bonella F, Brown KK, Collard HR, Corte TJ, Flaherty KR, Johannson KA, Kolb M, Kreuter M, Inoue Y, Jenkins RG, Lee JS, Lynch DA, Maher TM, …
• Reply: Possible Alternate Explanation for Cases of Idiopathic Pulmonary Fibrosis.
  Annals of the American Thoracic Society 2022 Kaul B, Lee JS, Collard HR, Whooley MA
• Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis.
  Chest 2022 DeDent AM, Collard HR, Thakur N
• Epidemiology of Idiopathic Pulmonary Fibrosis among U.S. Veterans, 2010-2019.
  Annals of the American Thoracic Society 2022 Kaul B, Lee JS, Zhang N, Vittinghoff E, Sarmiento K, Collard HR, Whooley MA
• Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosis.
  Thorax 2021 Avitzur N, Noth EM, Lamidi M, Nathan SD, Collard HR, DeDent AM, Thakur N, Johannson KA
• Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease.
  Chest 2021 Comes A, Wong AW, Fisher JH, Morisset J, Johannson KA, Farrand E, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Sadatsafavi M, Shapera S, To T, Wilcox PG, Collard HR,…
• Variability in Global Prevalence of Interstitial Lung Disease.
  Frontiers in medicine 2021 Kaul B, Cottin V, Collard HR, Valenzuela C
• Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World.
  Frontiers in medicine 2021 Polke M, Kondoh Y, Wijsenbeek M, Cottin V, Walsh SLF, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte TJ, Flaherty K, Funke-Chambour M, Kolb M, Krisam J, Maher TM, Molina Molina M, …
• Looking Ahead: Interstitial Lung Disease Diagnosis and Management in 2030.
  Clinics in chest medicine 2021 Johannson KA, Collard HR, Richeldi L
• Progress and Innovation in Interstitial Lung Disease.
  Clinics in chest medicine 2021 Johannson KA, Collard HR, Richeldi L
• Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: A scoping review.
  Respiratory medicine 2021 Barnes H, Lu J, Glaspole I, Collard HR, Johannson KA
• Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients.
  Chest 2020 Farrand E, Iribarren C, Vittinghoff E, Levine-Hall T, Ley B, Minowada G, Collard HR
• Is corticosteroid use truly not associated with improved outcomes in AE-IPF? - Reply.
  Respirology (Carlton, Vic.) 2020 Farrand E, Collard HR
• Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation.
  The European respiratory journal 2020 Kreuter M, Polke M, Walsh SLF, Krisam J, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte T, Flaherty K, Funke-Chambour M, Kolb M, Kondoh Y, Maher TM, Molina Molina M, Morais A, Moor CC, …
• Differences in Clinical Characteristics and Outcomes Between Men and Women With Idiopathic Pulmonary Fibrosis: A Multicenter Retrospective Cohort Study.
  Chest 2020 Zaman T, Moua T, Vittinghoff E, Ryu JH, Collard HR, Lee JS
• A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis.
  Chest 2020 Barnes H, Morisset J, Molyneaux P, Westall G, Glaspole I, Collard HR, CHP Exposure Assessment Collaborators
• Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
  Respirology (Carlton, Vic.) 2019 Farrand E, Vittinghoff E, Ley B, Butte AJ, Collard HR
• Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes.
  Scientific reports 2019 Casanova N, Zhou T, Gonzalez-Garay ML, Rosas IO, Goldberg HJ, Ryter SW, Collard HR, El-Chemaly S, Flaherty KR, Hunninghake GM, Lasky JA, Lederer DJ, Machado RF, Martinez FJ, Noth I, Raghu G, Choi AMK,…
• Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity.
  American journal of respiratory and critical care medicine 2019 Richeldi L, Cottin V, Brown KK, Flaherty KR, Johannson KA, Travis WD, Collard HR
• Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.
  The Lancet. Respiratory medicine 2019 Nathan SD, Behr J, Collard HR, Cottin V, Hoeper MM, Martinez FJ, Corte TJ, Keogh AM, Leuchte H, Mogulkoc N, Ulrich S, Wuyts WA, Yao Z, Boateng F, Wells AU
• Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
  American journal of respiratory and critical care medicine 2019 Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, …
• Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.
  Chest 2019 Liu GY, Ventura IB, Achtar-Zadeh N, Elicker BM, Jones KD, Wolters PJ, Collard HR, Adegunsoye A, Strek ME, Ley B
• Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
  The European respiratory journal 2019 Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C
• Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data.
  American journal of respiratory and critical care medicine 2019 Farrand E, Anstrom KJ, Bernard G, Butte AJ, Iribarren C, Ley B, Martinez FJ, Collard HR
• Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumonia.
  Histopathology 2019 Tanizawa K, Ley B, Vittinghoff E, Elicker BM, Henry TS, Wolters PJ, Brownell R, Liu S, Collard HR, Jones KD
• The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study.
  The European respiratory journal 2019 Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C
• Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
  American journal of respiratory and critical care medicine 2018 Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal…
• Response.
  Chest 2018 Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, Collard HR
• Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.
  The Lancet. Respiratory medicine 2018 Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom …
• Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis.
  Annals of the American Thoracic Society 2018 Guler SA, Ellison K, Algamdi M, Collard HR, Ryerson CJ
• Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials.
  The Lancet. Respiratory medicine 2018 Neighbors M, Cabanski CR, Ramalingam TR, Sheng XR, Tew GW, Gu C, Jia G, Peng K, Ray JM, Ley B, Wolters PJ, Collard HR, Arron JR
• Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
  The Lancet. Respiratory medicine 2018 Dressen A, Abbas AR, Cabanski C, Reeder J, Ramalingam TR, Neighbors M, Bhangale TR, Brauer MJ, Hunkapiller J, Reeder J, Mukhyala K, Cuenco K, Tom J, Cowgill A, Vogel J, Forrest WF, Collard HR, Wolters…
• Reply to Moodley: A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease.
  American journal of respiratory and critical care medicine 2018 Ryerson CJ, Walsh SLF, Collard HR, all authors
• Air Pollution Exposure Is Associated With Lower Lung Function, but Not Changes in Lung Function, in Patients With Idiopathic Pulmonary Fibrosis.
  Chest 2018 Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, Collard HR
• Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey.
  American journal of respiratory and critical care medicine 2017 Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SLF, Ley B, HP Delphi Collaborators
• A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.
  American journal of respiratory and critical care medicine 2017 Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, Behr J, Cottin V, Danoff SK, Flaherty KR, Lederer DJ, Lynch DA, Martinez FJ, Raghu G, Travis WD, Udwadia Z, Wells AU, Collard HR
• Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.
  American journal of respiratory and critical care medicine 2017 Cottin V, Hansell DM, Sverzellati N, Weycker D, Antoniou KM, Atwood M, Oster G, Kirchgaessler KU, Collard HR, Wells AU
• A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.
  Chest 2017 Rosas IO, Goldberg HJ, Collard HR, El-Chemaly S, Flaherty K, Hunninghake GM, Lasky JA, Lederer DJ, Machado R, Martinez FJ, Maurer R, Teller D, Noth I, Peters E, Raghu G, Garcia JGN, Choi AMK
• Idiopathic pulmonary fibrosis.
  Nature reviews. Disease primers 2017 Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU
• COUNTERPOINT: Should BAL Be Routinely Performed in the Diagnostic Evaluation of Idiopathic Pulmonary Fibrosis? No.
  Chest 2017 Mooney JJ, Collard HR
• Rebuttal From Drs Mooney and Collard.
  Chest 2017 Mooney JJ, Collard HR
• Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.
  BMJ open respiratory research 2017 Flaherty KR, Brown KK, Wells AU, Clerisme-Beaty E, Collard HR, Cottin V, Devaraj A, Inoue Y, Le Maulf F, Richeldi L, Schmidt H, Walsh S, Mezzanotte W, Schlenker-Herceg R
• Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.
  American journal of respiratory and critical care medicine 2017 Ley B, Swigris J, Day BM, Stauffer JL, Raimundo K, Chou W, Collard HR
• Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.
  Frontiers in medicine 2017 Oldham JM, Collard HR
• Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.
  The European respiratory journal 2017 Johannson KA, Vittinghoff E, Morisset J, Lee JS, Balmes JR, Collard HR
• The Hospitalized Patient with Interstitial Lung Disease: A Hospitalist Primer.
  Journal of hospital medicine 2017 Farrand E, Shah R, Collard H
• Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model.
  Chest 2017 Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE, Collard HR, Lee JS
• Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.
  Annals of the American Thoracic Society 2017 Ley B, Urbania T, Husson G, Vittinghoff E, Brush DR, Eisner MD, Iribarren C, Collard HR
• Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.
  The European respiratory journal 2017 Collard HR, Richeldi L, Kim DS, Taniguchi H, Tschoepe I, Luisetti M, Roman J, Tino G, Schlenker-Herceg R, Hallmann C, du Bois RM
• Giants in Chest Medicine: Talmadge E. King Jr, MD, FCCP.
  Chest 2017 Collard HR
• The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.
  Respiratory medicine 2017 Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE, Kim DS, Collard HR, Lee JS
• Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
  Respiratory medicine 2017 Natalini JG, Swigris JJ, Morisset J, Elicker BM, Jones KD, Fischer A, Collard HR, Lee JS
• Idiopathic pulmonary fibrosis.
  Lancet (London, England) 2017 Richeldi L, Collard HR, Jones MG
• CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis.
  Thorax 2017 Jia G, Chandriani S, Abbas AR, DePianto DJ, N'Diaye EN, Yaylaoglu MB, Moore HM, Peng I, DeVoss J, Collard HR, Wolters PJ, Egen JG, Arron JR
• Improving Survival in Idiopathic Pulmonary Fibrosis: The Race Has Just Begun.
  Chest 2017 Collard HR
• Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity Pneumonitis.
  Chest 2017 Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, Assayag D, Lee J, Wolters PJ, Collard HR, Koth LL
• Reply: Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
  American journal of respiratory and critical care medicine 2017 Corte TJ, Ryerson CJ, Collard HR
• Reply: The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air.
  American journal of respiratory and critical care medicine 2017 Ryerson CJ, Corte TJ, Martinez FJ, Collard HR
• The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.
  Thorax 2017 Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE, Wolters PJ, Collard HR, Ley B
• Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.
  The Lancet. Respiratory medicine 2016 Raghu G, Brown KK, Collard HR, Cottin V, Gibson KF, Kaner RJ, Lederer DJ, Martinez FJ, Noble PW, Song JW, Wells AU, Whelan TP, Wuyts W, Moreau E, Patterson SD, Smith V, Bayly S, Chien JW, Gong Q, …
• The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.
  The Lancet. Respiratory medicine 2016 Martinez FJ, Chisholm A, Collard HR, Flaherty KR, Myers J, Raghu G, Walsh SL, White ES, Richeldi L
• Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?
  Respiratory medicine 2016 Nathan SD, Behr J, Cottin V, Collard HR, Hoeper MM, Martinez FJ, Wells AU
• Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.
  Chest 2016 Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dubé BP, Wolters PJ, Collard HR, Ryerson CJ, Ley B
• A new era in idiopathic interstitial pneumonias: Epilogue to a review series.
  Respirology (Carlton, Vic.) 2016 Corte TJ, Collard H, Wells AU
• Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.
  American journal of respiratory and critical care medicine 2016 Ley B, Bradford WZ, Vittinghoff E, Weycker D, du Bois RM, Collard HR
• Hispanics/Latinos With Type 2 Diabetes Have Functional and Symptomatic Pulmonary Impairment Mirroring Kidney Microangiopathy: Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
  Diabetes care 2016 Klein OL, Aviles-Santa L, Cai J, Collard HR, Kanaya AM, Kaplan RC, Kinney GL, Mendes E, Smith L, Talavera G, Wu D, Daviglus M
• Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
  The European respiratory journal 2016 Newton CA, Batra K, Torrealba J, Kozlitina J, Glazer CS, Aravena C, Meyer K, Raghu G, Collard HR, Garcia CK
• Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
  American journal of respiratory and critical care medicine 2016 Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, Behr J, Brown KK, Cottin V, Flaherty KR, Fukuoka J, Hansell DM, Johkoh T, Kaminski N, Kim DS…
• The Unmet Educational Needs of Patients with Interstitial Lung Disease. Setting the Stage for Tailored Pulmonary Rehabilitation.
  Annals of the American Thoracic Society 2016 Morisset J, Dubé BP, Garvey C, Bourbeau J, Collard HR, Swigris JJ, Lee JS
• miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.
  PloS one 2016 Disayabutr S, Kim EK, Cha SI, Green G, Naikawadi RP, Jones KD, Golden JA, Schroeder A, Matthay MA, Kukreja J, Erle DJ, Collard HR, Wolters PJ
• Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia.
  BMC genetics 2016 Fingerlin TE, Zhang W, Yang IV, Ainsworth HC, Russell PH, Blumhagen RZ, Schwarz MI, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch DA, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, …
• Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis.
  American journal of respiratory and critical care medicine 2016 Brownell R, Kaminski N, Woodruff PG, Bradford WZ, Richeldi L, Martinez FJ, Collard HR
• A diagnostic model for chronic hypersensitivity pneumonitis.
  Thorax 2016 Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR
• Acetylcysteine in IPF: the knockout blow?
  The Lancet. Respiratory medicine 2016 Wijsenbeek MS, Collard HR
• Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
  The European respiratory journal 2016 Raghu G, Chen SY, Hou Q, Yeh WS, Collard HR
• Management of Myositis-Related Interstitial Lung Disease.
  Chest 2016 Morisset J, Johnson C, Rich E, Collard HR, Lee JS
• Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened.
  The European respiratory journal 2016 Fischer A, Collard HR, Cottin V, “ERS/ATS Task Force on Undifferentiated Forms of Connective Tissue Disease-associated Interstitial L
• Multidisciplinary Approach to Hypersensitivity Pneumonitis.
  Journal of thoracic imaging 2016 Elicker BM, Jones KD, Henry TS, Collard HR
• Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes.
  Scientific reports 2016 Withana NP, Ma X, McGuire HM, Verdoes M, van der Linden WA, Ofori LO, Zhang R, Li H, Sanman LE, Wei K, Yao S, Wu P, Li F, Huang H, Xu Z, Wolters PJ, Rosen GD, Collard HR, Zhu Z, Cheng Z, Bogyo M
• Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.
  American journal of respiratory and critical care medicine 2016 Costabel U, Inoue Y, Richeldi L, Collard HR, Tschoepe I, Stowasser S, Azuma A
• Gastroesophageal Reflux in Idiopathic Pulmonary Fibrosis: More than a Gut Feeling?
  Respiration; international review of thoracic diseases 2016 Wuyts WA, Collard HR
• Idiopathic pulmonary fibrosis: continuing to make progress.
  The Lancet. Respiratory medicine 2015 Lee JS, Collard HR
• House of Cards? Testing Fundamental Assumptions in Idiopathic Pulmonary Fibrosis Epidemiology.
  American journal of respiratory and critical care medicine 2015 Ley B, Collard HR
• Reply: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?
  American journal of respiratory and critical care medicine 2015 Richeldi L, Le Maulf F, Schlenker-Herceg R, Collard HR
• The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes.
  Chest 2015 Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner RJ, IPFnet Investigators
• Interstitial lung diseases in the hospitalized patient.
  BMC medicine 2015 Disayabutr S, Calfee CS, Collard HR, Wolters PJ
• Models of disease behavior in idiopathic pulmonary fibrosis.
  BMC medicine 2015 Johannson KA, Ley B, Collard HR
• Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
  European respiratory review : an official journal of the European Respiratory Society 2015 Harari S, Humbert M, Blasi F, Collard HR, Matucci-Cerinic M, Simonneau G, Vancheri C, Wells AU, Cottin V
• Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria.
  Respiratory medicine 2015 Assayag D, Kim EJ, Elicker BM, Jones KD, Golden JA, King TE, Koth LL, Shum AK, Wolters PJ, Collard HR, Lee JS
• Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
  The European respiratory journal 2015 Ryerson CJ, Cottin V, Brown KK, Collard HR
• An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
  American journal of respiratory and critical care medicine 2015 Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, …
• An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
  The European respiratory journal 2015 Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V…
• Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
  Annals of the American Thoracic Society 2015 Collard HR, Chen SY, Yeh WS, Li Q, Lee YC, Wang A, Raghu G
• The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.
  Respiratory medicine 2015 Assayag D, Vittinghoff E, Ryerson CJ, Cocconcelli E, Tonelli R, Hu X, Elicker BM, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Shum AK, Wolters PJ, Ryu JH, Collard HR
• Idiopathic interstitial pneumonias in 2015: A new era.
  Respirology (Carlton, Vic.) 2015 Corte TJ, Collard H, Wells AU
• Where do we go from here? Clinical drug development in idiopathic pulmonary fibrosis.
  The European respiratory journal 2015 Collard HR
• A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials.
  The European respiratory journal 2015 Collard HR, Bradford WZ, Cottin V, Flaherty KR, King TE, Koch GG, Kolb M, Martinez FJ, Montgomery B, Raghu G, Richeldi L, Rose D, Wells AU, Brown KK
• Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.
  The Lancet. Respiratory medicine 2015 Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King TE, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, Martinez FJ, IPFnet investigators
• Nintedanib in the treatment of idiopathic pulmonary fibrosis.
  Therapeutic advances in respiratory disease 2015 Mazzei ME, Richeldi L, Collard HR
• Air pollution exposure: a novel environmental risk factor for interstitial lung disease?
  Chest 2015 Johannson KA, Balmes JR, Collard HR
• Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis.
  The European respiratory journal 2015 Ley B, Bradford WZ, Weycker D, Vittinghoff E, du Bois RM, Collard HR
• Pharmacological treatment of idiopathic pulmonary fibrosis: an update.
  Drug discovery today 2015 Spagnolo P, Wells AU, Collard HR
• Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis.
  Chest 2014 Collard HR, Brown KK, Martinez FJ, Raghu G, Roberts RS, Anstrom KJ
• Open-access biorepository for idiopathic pulmonary fibrosis. The way forward.
  Annals of the American Thoracic Society 2014 White ES, Brown KK, Collard HR, Conoscenti CS, Cosgrove GP, Flaherty KR, Leff JA, Martinez FJ, Roman J, Rose D, Violette S, Kaminski N
• Molecular biomarkers in idiopathic pulmonary fibrosis.
  American journal of physiology. Lung cellular and molecular physiology 2014 Ley B, Brown KK, Collard HR
• Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
  Thorax 2014 DePianto DJ, Chandriani S, Abbas AR, Jia G, N'Diaye EN, Caplazi P, Kauder SE, Biswas S, Karnik SK, Ha C, Modrusan Z, Matthay MA, Kukreja J, Collard HR, Egen JG, Wolters PJ, Arron JR
• Acute exacerbations complicating interstitial lung disease.
  Current opinion in pulmonary medicine 2014 Ryerson CJ, Collard HR
• A global registry for idiopathic pulmonary fibrosis: the time is now.
  The European respiratory journal 2014 Ryerson CJ, Corte TJ, Collard HR, Richeldi L
• Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review.
  Chest 2014 Winstone TA, Assayag D, Wilcox PG, Dunne JV, Hague CJ, Leipsic J, Collard HR, Ryerson CJ
• Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.
  Thorax 2014 Ryerson CJ, Collard HR
• Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
  The Lancet. Respiratory medicine 2014 Stuart BD, Lee JS, Kozlitina J, Noth I, Devine MS, Glazer CS, Torres F, Kaza V, Girod CE, Jones KD, Elicker BM, Ma SF, Vij R, Collard HR, Wolters PJ, Garcia CK
• Idiopathic pulmonary fibrosis: CT and risk of death.
  Radiology 2014 Ley B, Elicker BM, Hartman TE, Ryerson CJ, Vittinghoff E, Ryu JH, Lee JS, Jones KD, Richeldi L, King TE, Collard HR
• A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.
  Chest 2014 Lubin M, Chen H, Elicker B, Jones KD, Collard HR, Lee JS
• Staging of idiopathic pulmonary fibrosis: past, present and future.
  European respiratory review : an official journal of the European Respiratory Society 2014 Kolb M, Collard HR
• Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts.
  Journal of immunology (Baltimore, Md. : 1950) 2014 Chandriani S, DePianto DJ, N'Diaye EN, Abbas AR, Jackman J, Bevers J, Ramirez-Carrozzi V, Pappu R, Kauder SE, Toy K, Ha C, Modrusan Z, Wu LC, Collard HR, Wolters PJ, Egen JG, Arron JR
• Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
  The Lancet. Respiratory medicine 2014 Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR
• Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
  The New England journal of medicine 2014 Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M,…
• Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT.
  The Lancet. Respiratory medicine 2014 Johannson KA, de Boer K, Wolters PJ, Golden JA, Lee JS, Collard HR
• Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis.
  Respiratory medicine 2014 Richeldi L, Cottin V, Flaherty KR, Kolb M, Inoue Y, Raghu G, Taniguchi H, Hansell DM, Nicholson AG, Le Maulf F, Stowasser S, Collard HR
• Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
  Chest 2014 Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE, Collard HR
• A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.
  Chest 2014 Doyle TJ, Lee JS, Dellaripa PF, Lederer JA, Matteson EL, Fischer A, Ascherman DP, Glassberg MK, Ryu JH, Danoff SK, Brown KK, Collard HR, Rosas IO
• Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.
  American journal of respiratory and critical care medicine 2014 Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty …
• Predictors of mortality in rheumatoid arthritis-related interstitial lung disease.
  Respirology (Carlton, Vic.) 2013 Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ
• Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
  Thorax 2013 Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, …
• Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study.
  Respiratory medicine 2013 Ryerson CJ, Cayou C, Topp F, Hilling L, Camp PG, Wilcox PG, Khalil N, Collard HR, Garvey C
• Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.
  Current respiratory care reports 2013 Johannson K, Collard HR
• Epidemiology of idiopathic pulmonary fibrosis.
  Clinical epidemiology 2013 Ley B, Collard HR
• Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.
  The European respiratory journal 2013 Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, Kim DS, Collard HR
• Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern.
  Radiology 2013 Assayag D, Elicker BM, Urbania TH, Colby TV, Kang BH, Ryu JH, King TE, Collard HR, Kim DS, Lee JS
• An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
  American journal of respiratory and critical care medicine 2013 Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M…
• Pathogenesis of idiopathic pulmonary fibrosis.
  Annual review of pathology 2013 Wolters PJ, Collard HR, Jones KD
• Update on the diagnosis and classification of ILD.
  Current opinion in pulmonary medicine 2013 Ryerson CJ, Collard HR
• Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis.
  Chest 2013 Mooney JJ, Elicker BM, Urbania TH, Agarwal MR, Ryerson CJ, Nguyen MLT, Woodruff PG, Jones KD, Collard HR, King TE, Koth LL
• Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.
  Respiratory research 2013 Collard HR, Yow E, Richeldi L, Anstrom KJ, Glazer C, IPFnet investigators
• Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.
  Chest 2013 Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE, Ryu J, Collard HR
• Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
  The Lancet. Respiratory medicine 2013 Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G, IPFnet Investigators
• Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.
  American journal of respiratory and critical care medicine 2013 Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK
• Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis.
  The European respiratory journal 2013 Richeldi L, Collard HR, du Bois RM, Jenkins G, Kolb M, Maher TM, Raghu G, Vancheri C, Laurent GJ
• Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
  Annals of internal medicine 2013 Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen…
• Outcomes in systemic sclerosis-related lung disease after lung transplantation.
  Transplantation 2013 Sottile PD, Iturbe D, Katsumoto TR, Connolly MK, Collard HR, Leard LA, Hays S, Golden JA, Hoopes C, Kukreja J, Singer JP
• Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
  Nature genetics 2013 Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS,…
• Prevalence and prognosis of unclassifiable interstitial lung disease.
  The European respiratory journal 2012 Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR
• Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.
  Respiratory medicine 2012 Lee JS, Kim EJ, Lynch KL, Elicker B, Ryerson CJ, Katsumoto TR, Shum AK, Wolters PJ, Cerri S, Richeldi L, Jones KD, King TE, Collard HR
• Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis.
  Respiratory research 2012 Cha SI, Ryerson CJ, Lee JS, Kukreja J, Barry SS, Jones KD, Elicker BM, Kim DS, Papa FR, Collard HR, Wolters PJ
• Clinical year in review IV: HIV, mycobacterial disease, pulmonary hypertension, and interstitial lung disease.
  Proceedings of the American Thoracic Society 2012 Collard HR, Morris A, Daley CL, Humbert M, Meyer KC
• Idiopathic pulmonary fibrosis.
  Seminars in respiratory and critical care medicine 2012 Adkins JM, Collard HR
• A multidimensional index and staging system for idiopathic pulmonary fibrosis.
  Annals of internal medicine 2012 Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE, Collard HR
• Burden of illness in idiopathic pulmonary fibrosis.
  Journal of medical economics 2012 Collard HR, Ward AJ, Lanes S, Cortney Hayflinger D, Rosenberg DM, Hunsche E
• Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
  American journal of respiratory and critical care medicine 2012 Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK
• Depression is a common and chronic comorbidity in patients with interstitial lung disease.
  Respirology (Carlton, Vic.) 2012 Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR
• Reduced lung diffusion capacity in type 2 diabetes is independent of heart failure.
  Diabetes research and clinical practice 2012 Klein OL, Jones M, Lee J, Collard HR, Smith LJ
• Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis.
  Thorax 2012 Richeldi L, Ryerson CJ, Lee JS, Wolters PJ, Koth LL, Ley B, Elicker BM, Jones KD, King TE, Ryu JH, Collard HR
• Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.
  Histopathology 2012 Cha SI, Chang CS, Kim EK, Lee JW, Matthay MA, Golden JA, Elicker BM, Jones K, Collard HR, Wolters PJ
• Interstitial lung diseases. Preface.
  Clinics in chest medicine 2012 King TE, Collard HR, Richeldi L
• Dyspnea in idiopathic pulmonary fibrosis: a systematic review.
  Journal of pain and symptom management 2012 Ryerson CJ, Donesky D, Pantilat SZ, Collard HR
• Risk prediction in idiopathic pulmonary fibrosis.
  American journal of respiratory and critical care medicine 2012 Ley B, Collard HR
• Comprehensive care of the patient with idiopathic pulmonary fibrosis.
  Current opinion in pulmonary medicine 2011 Lee JS, McLaughlin S, Collard HR
• Cough predicts prognosis in idiopathic pulmonary fibrosis.
  Respirology (Carlton, Vic.) 2011 Ryerson CJ, Abbritti M, Ley B, Elicker BM, Jones KD, Collard HR
• Primum non nocere: safety in clinical trials for IPF.
  Respirology (Carlton, Vic.) 2011 Lee JS, Collard HR
• Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.
  American journal of respiratory and critical care medicine 2011 Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE, Collard HR
• An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
  American journal of respiratory and critical care medicine 2011 Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M,…
• Viral infection in acute exacerbation of idiopathic pulmonary fibrosis.
  American journal of respiratory and critical care medicine 2011 Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, Huh JW, Taniguchi H, Chiu C, Boushey H, Lancaster LH, Wolters PJ, DeRisi J, Ganem D, Collard HR
• Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
  American journal of respiratory and critical care medicine 2010 Ley B, Collard HR, King TE
• Depression and functional status are strongly associated with dyspnea in interstitial lung disease.
  Chest 2010 Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR
• Pulmonary rehabilitation for interstitial lung disease.
  Chest 2010 Ryerson CJ, Garvey C, Collard HR
• Management of dyspnea in interstitial lung disease.
  Current opinion in supportive and palliative care 2010 Ryerson CJ, Collard HR, Pantilat SZ
• A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
  The New England journal of medicine 2010 Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW
• Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.
  American journal of physiology. Lung cellular and molecular physiology 2010 Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE, Matthay MA, Kim DS
• The age of idiopathic pulmonary fibrosis.
  American journal of respiratory and critical care medicine 2010 Collard HR
• Does chronic microaspiration cause idiopathic pulmonary fibrosis?
  The American journal of medicine 2010 Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King TE
• Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function.
  Lung 2010 Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE
• Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.
  Chest 2009 Kim EJ, Collard HR, King TE
• Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.
  Chest 2009 Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA
• Silicone injection causing acute pneumonitis: a case series.
  Lung 2009 Zamora AC, Collard HR, Barrera L, Mendoza F, Webb WR, Carrillo G
• Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response.
  Chest 2008 Ferreira A, Garvey C, Connors GL, Hilling L, Rigler J, Farrell S, Cayou C, Shariat C, Collard HR
• Dyspnea in interstitial lung disease.
  Current opinion in supportive and palliative care 2008 Collard HR, Pantilat SZ
• Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.
  Respiratory medicine 2007 Zamora AC, Wolters PJ, Collard HR, Connolly MK, Elicker BM, Webb WR, King TE, Golden JA
• A practical guide for clinicians who treat patients with amiodarone: 2007.
  Heart rhythm 2007 Goldschlager N, Epstein AE, Naccarelli GV, Olshansky B, Singh B, Collard HR, Murphy E, Practice Guidelines Sub-committee, North American Society of Pacing and Electrophysiology (HRS)
• Acute exacerbations of idiopathic pulmonary fibrosis.
  American journal of respiratory and critical care medicine 2007 Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, …
• Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
  American journal of respiratory and critical care medicine 2007 Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE
• Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians.
  Respiratory medicine 2007 Collard HR, Loyd JE, King TE, Lancaster LH
• In response to Silvestri.
  American journal of infection control 2007 Flanders SA, Saint S, Collard HR
• On beyond zebra: understanding rare diseases.
  Chest 2007 Collard HR
• Sildenafil improves walk distance in idiopathic pulmonary fibrosis.
  Chest 2007 Collard HR, Anstrom KJ, Schwarz MI, Zisman DA
• Patient experiences with pulmonary fibrosis.
  Respiratory medicine 2006 Collard HR, Tino G, Noble PW, Shreve MA, Michaels M, Carlson B, Schwarz MI
• Anticoagulant therapy and idiopathic pulmonary fibrosis.
  Chest 2006 Kinder BW, Collard HR, King TE
• Classification and natural history of the idiopathic interstitial pneumonias.
  Proceedings of the American Thoracic Society 2006 Kim DS, Collard HR, King TE
• Current perspectives on the treatment of idiopathic pulmonary fibrosis.
  Proceedings of the American Thoracic Society 2006 Walter N, Collard HR, King TE
• Nosocomial pneumonia: state of the science.
  American journal of infection control 2006 Flanders SA, Collard HR, Saint S
• Clinical problem-solving. A perfect storm.
  The New England journal of medicine 2005 Janssen WJ, Collard HR, Saint S, Weinberger SE
• Clinical and economic consequences of ventilator-associated pneumonia: a systematic review.
  Critical care medicine 2005 Safdar N, Dezfulian C, Collard HR, Saint S
• Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis.
  The American journal of medicine 2005 Dezfulian C, Shojania K, Collard HR, Kim HM, Matthay MA, Saint S
• Clinical problem-solving. Why "why" matters.
  The New England journal of medicine 2004 Janssen WJ, Dhaliwal G, Collard HR, Saint S
• Diffuse alveolar hemorrhage.
  Clinics in chest medicine 2004 Collard HR, Schwarz MI
• Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.
  Chest 2004 Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE, Brown KK
• Prognosis in idiopathic pulmonary fibrosis.
  American journal of respiratory and critical care medicine 2004 Thabut G, Fournier M, Collard HR, Brown KK
• Clinical problem-solving. Anatomy of a diagnosis.
  The New England journal of medicine 2003 Collard HR, Gruber MP, Weinberger SE, Saint S
• Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.
  American journal of respiratory and critical care medicine 2003 Collard HR, King TE, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK
• Prevention of ventilator-associated pneumonia: an evidence-based systematic review.
  Annals of internal medicine 2003 Collard HR, Saint S, Matthay MA
• Demystifying idiopathic interstitial pneumonia.
  Archives of internal medicine 2003 Collard HR, King TE